Intuitive Surgical Stock (NASDAQ:ISRG)



Previous Close

$481.34

52W Range

$364.31 - $616.00

50D Avg

$528.23

200D Avg

$510.97

Market Cap

$172.95B

Avg Vol (3M)

$2.28M

Beta

1.56

Div Yield

-

ISRG Company Profile


Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

15,638

IPO Date

Jun 16, 2000

Website

ISRG Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23Dec 22
Instruments and Accessories$5.08B$4.28B-
Systems$1.97B$1.68B-
Services$1.31B$1.17B-
Service-$1.17B-
Product--$5.20B

Fiscal year ends in Dec 24 | Currency in USD

ISRG Financial Summary


Dec 24Dec 23Dec 22
Revenue$8.35B$7.12B$6.22B
Operating Income$2.35B$1.77B$1.21B
Net Income$2.32B$1.80B$1.32B
EBITDA$2.67B$2.17B$1.94B
Basic EPS$6.54$5.12$3.72
Diluted EPS$6.42$5.03$3.65

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Jan 23, 25 | 4:30 PM
Q3 24Oct 17, 24 | 4:30 PM
Q2 24Jul 18, 24 | 4:30 PM

Peer Comparison


TickerCompany
RGENRepligen Corporation
LUCYInnovative Eyewear, Inc.
NXGLNEXGEL, Inc.
EMBCEmbecta Corp.
BAXBaxter International Inc.
RMDResMed Inc.
ICUIICU Medical, Inc.
HOLXHologic, Inc.
BDXBecton, Dickinson and Company
MMSIMerit Medical Systems, Inc.
COOThe Cooper Companies, Inc.
WSTWest Pharmaceutical Services, Inc.
TFXTeleflex Incorporated
BNGOBionano Genomics, Inc.